Salix Will Present XIFAXAN(R, TRULANCE and RELISTOR Data at Scientific Meeting
24 Oct 2022 //
ACCESSWIRE
Salix To Highlight New Data Across Its Portfolio Products At Digestive Disease
30 Apr 2020 //
PRNEWSWIRE
Cipher Pharma`s Receives Health Canada Approval For Trulance® (Plecanatide)
19 Oct 2019 //
BIOSPACE
Sun BioPharma founder Michael Cullen steps up; SemaThera settles on CEO
02 Nov 2018 //
ENDPTS
Synergy Pharmaceuticals Provides Business Update
28 Oct 2018 //
BUSINESSWIRE
After 3 years of hunting a buyer, Trulance maker Synergy desperate for cash
26 Oct 2018 //
FIERCE PHARMA
Panel backing for key Shire drug beefs up Takeda`s case for its $62B buyout
20 Oct 2018 //
FIERCE PHARMA
Luoxin acquires constipation drug in $68 M agreement
09 Aug 2018 //
BIOSPECTRUM
Trulance, Yescarta head into the #FierceMadness Elite Eight
26 Mar 2018 //
FIERCE PHARMA
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals
28 Feb 2018 //
PRESS RELEASE
Toxicity knocks Ardelyx`s hyperkalemia hopes back to preclinic
21 Nov 2017 //
FIERCE BIOTECH
Synergy Pharmaceuticals to Present TRULANCE™ (Plecanatide) Phase 3 Data at (DDW)
08 May 2017 //
PHARMIWEB